
RSV vaccines could offer protection against asthma
Ghent, November 28, 2025 – Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling evidence that early-infancy infection with respiratory syncytial virus (RSV) significantly increases the risk of developing childhood asthma—especially in children with a family history of allergy or asthma. Their study, published today in Science Immunology, suggests that protecting newborns against RSV could substantially reduce asthma cases later in life.
Latest stories

Scientists map dendritic cell reactions to vaccines
Ghent, 26 August 2025 – Belgian scientists have uncovered new details about how the immune system responds to vaccines. Dendritic cells, which are key immune messengers that help kick-start the body’s defenses, show specific responses to lipid nanoparticles. These findings, published in Cell Reports, could lead to safer and more effective vaccines.
Contact us



.jpg)




